Epidemiology and clinical aspects of hematological malignancies at the military hospital of Antananarivo


  • Valéry Refeno Department of of Oncology, Professor Zafisaona Gabriel Teaching Hospital, Faculty of Medicine of Mahajanga, Mahajanga, Madagascar
  • Nomeharisoa R. E. Hasiniatsy Department of Oncology and Palliative Care, Military Hospital, Faculty of Medicine of Antananarivo, Antananarivo, Madagascar
  • Andriatsioharana V. N. Ramahandrisoa Department of Oncology, Joseph Ravoahangy Andrianavalona Teaching Hospital, Faculty of Medicine of Antananarivo, Antananarivo, Madagascar
  • Fanomezantsoa A. Rakoto Military Hospital, Faculty of Medicine of Antananarivo, Antananarivo, Madagascar
  • Aimée O. Rakoto Alson Department of Hematology, Joseph Ravoahangy Andrianavalona Teaching Hospital, Faculty of Medicine of Antananarivo, Antananarivo, Madagascar
  • Florine Rafaramino Faculty of Medicine of Antananarivo, Antananarivo, Madagascar




Clinical aspects, Epidemiology, Hematological malignancies, Military hospital, Madagascar


Background: Malignant hemopathies constitute a group of pathologies having in common the anomalies of the bone marrow or of the lymphatic system cells. In developed countries, the number and actual distribution of cancers is provided by cancer registries. In Madagascar there is no effective cancer registry and only two studies on malignant hemopathies have been carried out to date, but neither has described their epidemiology and clinical aspects. Thus, we aimed to describe the epidemiology and clinical aspects of malignant hemopathies managed in the Medical Oncology Unit of the Military Hospital of Antananarivo.

Methods: It was a cross-sectional and descriptive study carried out at this unit from 1st December 2012 to 31st August 2015 (33 months). Authors included all patients followed, then excluded those without pathologic evidence, cases of monoclonal gammapathy of unknown significance and cases of solid cancers.

Results: We followed up 57 cases of malignant hemopathies. The mean age was 49.39±15.46 years and the sex ratio was 1.71. Superficial lymphadenopathy was the most frequent warning signs (31.58%) and lymphomas were most represented (52.63%). There was a significant association between warning signs and diagnosis (p value <0.001).

Conclusions: Present results are grossly similar to those of other African authors. Present results are distinguished by a low proportion of chronic myeloid leukemia and a very low proportion of chronic lymphocytic leukemia compared to literature data. The effectiveness of the cancer registry will allow us to improve the knowledge about frequency and current distribution of cancer in Madagascar.


Rodriguez-Abreu D, Bordoni A, Zucca E. Epidemiology of hematological malignancies. Ann Oncol2007;18(Suppl 1):i3-8.

Ferlay J, soerjomataram I, Dihshit R, Eser S, Mathers C. Cancer incidence and mortality worldwide : sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer2012;136(5):E359-86.

Guyader-Peyrou S, Belot A, Maynadié M, Binder-Foucard F, Remontet L, Troussard X. Cancer incidence in France over the 1980-2012 period : Hamatological malignancies. Rev Epidémiologie Santé Publique. 2016;64(2):103‑12.

Babatunde A, Amiwero C, Olatunji P, Durotoye I. Pattern of haematological malignancies in Ilorin, Nigeria : a ten year review. Internet J Hematol. 2009;5(2):1.

Thiam D, Diop S, Diop T, Tallarmin F, Toure A, Diakhate L. Epidemiology and therapy of malignant hemopathies in Senegal. Hematol Cell Ther. 1996;38:187‑91.

Al-Ghazaly J, Al-Selwi A, Abdullah M, Al-Jahafi A, Al-Dubai W, Al-Hashdi A. Pattern of haematological diseases diagnosed by bone marrow examination in Yemen : a developing country experience. Clin Lab Haem. 2006;28:376‑81.

Ouédraogo S, Hien F, Bazié W, Millogo A, Brabo Y. Hematologic malignancies in internal medicine, university hospital of souro sanuo (Burkina Faso). Mali Med. 2011;26(3):17‑21.

Hasiniatsy N, Ramahandrisoa A, Refeno V, Rakoto F, Florine F. [Epidemiology of cancer managed in Medical Oncology at the Military Hospital of Antananarivo, Madagascar]. Bull Cancer. 2017;104:902‑6.

Rakoto Alson S, Raherimandimby H, Rakotoarison R, Ralaiarimanana L, Rakoto Alson A, Ralison G, et al. [Parodontal manifestations of hematological malignancies]. Rev Odontostomatol Malgache En Ligne. 2010;1:1‑8.

Hasiniatsy NRE, Refeno V, Ramahandrisoa A, Rakoto FA, Rakoto Alson AO, Rafaramino F. Therapeutic aspects and outcome of hematological malignancies at the military hospital of Antananarivo. J Arch Mil Med. 2018;6(4):e88005.

Ranaivomanana A, Hasiniatsy NRE, Randriamalala N, Rafaramino F. R 01. [The cancer managed at the Oncology Department CHU/JRA from 2009 to 2010]. Rev Med Madag. 2013;3(2):288‑93.

Errahhali M, Errahhali M, Boulouiz R, Ouarzana M, Bellaoui M. Distribution and features of hematological malignancies in Eastern Morocco : a retrospective multicenter study over 5 years. BMC Cancer. 2016;16:159.

Al-Kahiry W. Hematological malignancies in Al-Amal Oncology Unit, Aden. Indian J Hematol Blood Transfus. 2012;28(1):19‑23.

Ba Saleem H, Bawazir A, Moore M. Five years cancer incidence in Aden cancer registry. Yemen (2002-2006). Asian Pac J Cancer Prev. 2010;11:507‑11.

Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9‑29.

Koulidiati J, Ouedraogo D, Tieno H, Bationo B, Kafando E, Drabo Y. [Hematological malignancies of adults at Ouagadougou (Burkina Faso) : Epidemiological, diagnostic and therapeutic aspects]. Rev Cames Sante. 2015;3(2):10‑6.

Mahboub F, Elkhattabi W, L’youssfi H, Aichane A, Afif H. Positive diagnosis and evolution of hematological malignancies (about 132 cases). Rev Mal Respir. 2015;32(Suppl):A130.

Weldetsadik A. Clinical characteristics of patients with hematological malignancies at gondar university hospital, North West Ethiopia. Ethiop Med J. 2013;51(1):25‑31.

Kagu M, Ahmed S, Bukar A, Mohammed A, Mayun A, Musa A. Spectrum of haematological malignancies and survical outcomes of adult lymphomas in Maiduguri, North eastern Nigeria - a fourteen year review. Afr J Med Med Sci. 2013;42:5‑14.

Diallo D, Cissoko L, Cissoko Y, Diallo Y, Baby M, Mouhaha J. Current epidemiology of hematological malignancies at the Hematology, Medical Oncology and Internal Medicine Department of Point G, Bamako, Mali. Mali Méd. 2005;20(4):1‑8.

Téa D, Toutoukpo Y, Abissey A, Anoh J, Rain J. Overview of hemopathies diagnosed at central laboratory of Treichville Teaching Hospital : Review of 10 years of activity. Médecine Afr Noire. 1992;39(5):268‑9.

Kusum A, Negi G, Gaur D, Kishore S, Meena H, Sharma A. Hematological malignancies diagnosed by bone marrow examination in a tertiary hospital at Uttarakhand, India. Indian J Hematol Blood Transfus. 2008;24(1):7‑11.

Idris M, Shah S, Fareed J, Gul N. An experience with sixty cases of haematological malignancies ; a clinico haematological correlation. J Ayub Med Coll Abbottabad. 2004;16(4):51‑4.

Hossain M, Iqbal M, Khan M, Rabbani M, Khatun H, Munira S. Diagnosed hematological malignancies in Bangladesh -a retrospective analysis of over 5000 cases from 10 specialized hospitals. BMC Cancer. 2014;14:438.

Broccia G, Deplano W, Dessalvi P, Giannico B, Luxi G, Chessa E. Hematological malignancies in the island of sardinia, 1974-1993: age and sex distributions and temporal changes in incidence. Hematol Oncol. 2004;22:91‑109.

McNally R, Rowland D, Roman E, Cartwright R. Age and sex distribution of hematological malignancies in the U.K. Hematol Oncol.1997;15(4):173‑89.

Broccia G, Gabbas A, Longinotti M. Newly diagnosed malignancies in Sardinia in the early 2000s : an estimation of their number, age and geographic distribution on the basis of a previous epidemiologic survey. Haematologica. 2005;90(3):429‑30.

Sawadogo D, Yapo A, Sangeré M, Tolo A. [Epidemiological characteristics of patients with hematological malignancies at Abidjan during the decade 1995-2004]. J Afr Cancer. 2009;1:4‑10.

Yao A, Coze C, Traoré F, André N, Moreira C, Pondy S. [Management of pain of children with cancer in Africa : Situational analysis inside the Franco-African Group of Pediatric Oncology. Arch Pédiatrie. 2013;20:257‑64.

Smith A, Howell D, Patmore R, Jack A, Roman E. Incidence of haematological malignancy by sub-type : a report from the haematological Malignancy Research Report. Br J Cancer. 2011;105(11):1684‑92.

Harioly Nirina M, Rakotoarivelo Z, Ntoezara A, Rasolonjatovo A, Rakoto Alson A, Rasamindrakotroka A. Epidemiology and diagnosis of acute leukemia at the Ravoahangy Andrianavalona Hospital, Antananarivo, Madagascar. J Afr Cancer. 2015;7:186‑9.

Rakotonarivo J, Refeno V, Ramahandrisoa A, Rabarijaona L, Rafaramino F. Situational analysis of chronic myeloid leukemia at the Oncology Department of CHU/JRA. Rev Med Madag. 2013;3(2):288‑93.

Armstrong A, Alexander F, Cartwright R, Angus B, Krajewski A, Wright D. Epstein-Barr virus and Hodgkin’s disease : further evidence for three disease hypothesis. Leukemia. 1998;12(8):1272‑6.

Troussard X, Duchenet V, Cornet E, Mouchel D, Malet M, Collignon A. Haematological malignancies : incidence in Basse-Normandie, France, for 1997-2004. Rev Epidemiol Sante Publique. 2009;57(3):151‑8.

Cartwright R, Gurney K, Moorman A. Sex ratios and the risks of haematological malignancies. Br J Haematol2002;118(4):1071‑7.

Refeno V, Hasiniatsy N, Ramahandrisoa A, Razafimahefa H, Ramanampamonjy R, Rafaramino F. Secondary resistance of a GastroIntestinal Stromal Tumor (GIST) to imatinib : a case report. Rev Malgache Cancérologie2016;1(2):19‑26.




How to Cite

Refeno, V., Hasiniatsy, N. R. E., Ramahandrisoa, A. V. N., Rakoto, F. A., Rakoto Alson, A. O., & Rafaramino, F. (2019). Epidemiology and clinical aspects of hematological malignancies at the military hospital of Antananarivo. International Journal of Research in Medical Sciences, 7(6), 2037–2044. https://doi.org/10.18203/2320-6012.ijrms20192478



Original Research Articles